Day One Biopharmaceuticals, Inc. Profile Avatar - Palmy Investing

Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly …

Biotechnology
US, South San Francisco [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of DAWN's Analysis
CIK: 1845337 CUSIP: 23954D109 ISIN: US23954D1090 LEI: - UEI: -
Secondary Listings
DAWN has no secondary listings inside our databases.